252 related articles for article (PubMed ID: 30788233)
1. Medically inoperable stage I non-small cell lung cancer: best practices and long-term outcomes.
Choi JI
Transl Lung Cancer Res; 2019 Feb; 8(1):32-47. PubMed ID: 30788233
[TBL] [Abstract][Full Text] [Related]
2. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
[TBL] [Abstract][Full Text] [Related]
3. Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location.
Schonewolf CA; Heskel M; Doucette A; Singhal S; Frick MA; Xanthopoulos EP; Corradetti MN; Friedberg JS; Pechet TT; Christodouleas JP; Levin W; Berman A; Cengel KA; Verma V; Hahn SM; Kucharczuk JC; Rengan R; Simone CB
Clin Lung Cancer; 2019 Jan; 20(1):e63-e71. PubMed ID: 30337269
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis.
Nanda RH; Liu Y; Gillespie TW; Mikell JL; Ramalingam SS; Fernandez FG; Curran WJ; Lipscomb J; Higgins KA
Cancer; 2015 Dec; 121(23):4222-30. PubMed ID: 26348268
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC).
Lischalk JW; Woo SM; Kataria S; Aghdam N; Paydar I; Repka MC; Anderson ED; Collins BT
J Radiat Oncol; 2016; 5(4):379-387. PubMed ID: 28018523
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly.
Shinde A; Li R; Kim J; Salgia R; Hurria A; Amini A
Semin Oncol; 2018 Aug; 45(4):210-219. PubMed ID: 30286944
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiotherapy for early stage non-small cell lung cancer: current standards and ongoing research.
Vlaskou Badra E; Baumgartl M; Fabiano S; Jongen A; Guckenberger M
Transl Lung Cancer Res; 2021 Apr; 10(4):1930-1949. PubMed ID: 34012804
[TBL] [Abstract][Full Text] [Related]
8. Improved survival with stereotactic ablative radiotherapy (SABR) over lobectomy for early stage non-small cell lung cancer (NSCLC): addressing the fallout of disruptive randomized data.
Rusthoven CG; Kavanagh BD; Karam SD
Ann Transl Med; 2015 Jul; 3(11):149. PubMed ID: 26244136
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis.
Scotti V; Bruni A; Francolini G; Perna M; Vasilyeva P; Loi M; Simontacchi G; Viggiano D; Lanfranchi B; Gonfiotti A; Topulli J; Olmetto E; Maragna V; Ferrari K; Bonti V; Comin C; Balduzzi S; D'Amico R; Lohr F; Voltolini L; Livi L
Clin Lung Cancer; 2019 Jan; 20(1):e53-e61. PubMed ID: 30348595
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy With Curative Intent in Patients With Early-stage, Medically Inoperable, Non-Small-cell Lung Cancer: A Systematic Review.
Falkson CB; Vella ET; Yu E; El-Mallah M; Mackenzie R; Ellis PM; Ung YC
Clin Lung Cancer; 2017 Mar; 18(2):105-121.e5. PubMed ID: 27908621
[TBL] [Abstract][Full Text] [Related]
11. Additional data in the debate on stage I non-small cell lung cancer: surgery versus stereotactic ablative radiotherapy.
Simone CB; Dorsey JF
Ann Transl Med; 2015 Aug; 3(13):172. PubMed ID: 26366389
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiation therapy for non-small cell lung cancer: A review.
Prezzano KM; Ma SJ; Hermann GM; Rivers CI; Gomez-Suescun JA; Singh AK
World J Clin Oncol; 2019 Jan; 10(1):14-27. PubMed ID: 30627522
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.
Aridgides P; Bogart J
Thorac Surg Clin; 2016 Aug; 26(3):261-9. PubMed ID: 27427521
[TBL] [Abstract][Full Text] [Related]
14. Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinoma.
Kann BH; Verma V; Stahl JM; Ross R; Dosoretz AP; Shafman TD; Gross CP; Park HS; Yu JB; Decker RH
Radiother Oncol; 2019 May; 134():44-49. PubMed ID: 31005223
[TBL] [Abstract][Full Text] [Related]
15. Complications from Stereotactic Body Radiotherapy for Lung Cancer.
Kang KH; Okoye CC; Patel RB; Siva S; Biswas T; Ellis RJ; Yao M; Machtay M; Lo SS
Cancers (Basel); 2015 Jun; 7(2):981-1004. PubMed ID: 26083933
[TBL] [Abstract][Full Text] [Related]
16. Lung stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer in the very elderly (≥80years old): Extremely safe and effective.
Kreinbrink P; Blumenfeld P; Tolekidis G; Sen N; Sher D; Marwaha G
J Geriatr Oncol; 2017 Sep; 8(5):351-355. PubMed ID: 28739159
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC): contemporary insights and advances.
Sebastian NT; Xu-Welliver M; Williams TM
J Thorac Dis; 2018 Aug; 10(Suppl 21):S2451-S2464. PubMed ID: 30206491
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer.
Sun H; Wang H; Wei Y; Wang H; Jin C; Chen Y
Cost Eff Resour Alloc; 2023 Jul; 21(1):46. PubMed ID: 37507748
[TBL] [Abstract][Full Text] [Related]
19. Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer.
Nantavithya C; Gomez DR; Wei X; Komaki R; Liao Z; Lin SH; Jeter M; Nguyen QN; Li H; Zhang X; Poenisch F; Zhu XR; Balter PA; Feng L; Choi NC; Mohan R; Chang JY
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):558-563. PubMed ID: 29680255
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic body radiation therapy (SBRT) for patients with stage I non-small cell lung cancer is applicable to more tumors than sublobar resection.
Song AJ; Evans N; Cowan S; Guo J; Zhan T; Lu B; Werner-Wasik M
J Thorac Dis; 2021 Mar; 13(3):1576-1583. PubMed ID: 33841949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
